Yes a very good result , be interesting to see how it compared with other drugs currently available or in trials for ovarian cancer .
I feel management are competent but like you feel they are "lack lustre" when it comes to managing corporate affairs .
- Forums
- ASX - By Stock
- Ann: Cantrixil last patient visit
Yes a very good result , be interesting to see how it compared...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)